New Pilot Injection Targets Fat Cells
The experimental drug "CBL-514," administered via injection, represents a new approach to treating obesity by stimulating fat cells to undergo programmed cell death, effectively reducing the amount of fat in the body. This treatment aims to address obesity in a more sustainable and effective manner compared to traditional methods, and it is currently in the trial phases.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)